by In2Pharma | Jul 11, 2024 | News
The Netherlands Online advertising for self-care products by influencers is increasing significantly, raising concerns about control and misinformation. Influencer registry A registry of certified influencers was opened in April. These influencers annually complete an...
by In2Pharma | May 8, 2024 | News
The Netherlands GMH organizes multiple trainings on the regulation of premiums and benefits with regard to medical devices. They offer two levels of training: a basic training and a more advanced training. These trainings will take up one half of a day (before noon)...
by In2Pharma | Jan 11, 2023 | News
The Netherlands Marketing authorization holders who want to temporarily supply a medicine in a different packaging in the event of a medicine shortage will need permission from the MEB from 1 January 2023. The MEB will take over this task from the Healthcare and Youth...
by In2Pharma | Dec 12, 2022 | News
The Netherlands Drug shortages are an important issue since the COVID-19 pandemic. According to the Medicines Act, each Marketing Authorisation Holder (MAH) and Wholesaler must ensure that sufficient supply of each medicine is available. The interpretation of...
by In2Pharma | Feb 16, 2022 | News
The Netherlands Medicinal Product Quality Defects and Shortages on the Dutch Market should be reported through the “Meldpunt geneesmiddelentekorten en -defecten”. As of 01 January 2022, the Medicines Evaluation Board (MEB) and the Inspectorate (IGJ) have implemented...
